Sensex builds on gains, surges 249 pts in early trade

Date:

The benchmark BSE Sensex climbed 249 points in early trade today, extending its weekend rally on continued buying amid a firming trend overseas after a slowdown in US job creation dimmed expectations of an interest rate rise by the Fed this month.

Moreover, services sector growing at its fastest pace in over three-and-half years in August and the rupee rising against the dollar also supported trading sentiment.

The 30-share index surged 248.75 points or 0.87 per cent to 28,780.86 with all the sectoral indices led by realty, banking and auto trading higher.

The gauge had rallied 108.63 points in the previous session on Friday. Stock exchanges remained closed yesterday on account of ‘Ganesh Chaturthi’.

The NSE index Nifty too climbed 68.10 points or 0.77 per cent to 8,877.75.

Brokers said continued foreign fund inflows and persistent buying by investors amid a firming trend overseas buoyed trading sentiment.

A monthly PMI survey showing that India’s services sector growth touched the highest level in over three-and-a-half years of 54.7 in August, from 51.9 in July, too lifted the mood.

Among other Asian markets, Hong Kong’s Hang Seng was up 0.39 per cent and Japan’s Nikkei gained 0.22 per cent, however, Shanghai Composite Index shed 0.10 per cent in early trade in today.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

Popular

More like this
Related

IPL 2024: SRH Qualifies For Playoffs As Match Against Gujarat Abandoned Due To Rain

Sunrisers Hyderabad have officially became the third team to qualify for playoffs

Three Year Old Dead After Parent’s Forget Her In Car, Attend Wedding

As per the police, the incident occurred on Wednesday evening and the girl has been identified as Gorvika Nagar

IPL 2024: Toss Delayed In Sunrisers Hyderabad-Gujarat Titans Clash Due To Rain

It will be a crucial match for the Hyderabad-based franchise since they have to win the match to qualify for the playoffs of the IPL 2024

Another Rare Blood Disorder Linked To AstraZeneca Covid Vaccine Found

Researchers have found that the AstraZeneca vaccine sold in India under the brand name Covishield is linked to a rare blood clotting disorder known as Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT)